Pharma 3.0: Drug Companies Slowly Adapt to the New Tech World


The landscape of the pharmaceutical industry is changing, and companies need to adjust: That's been the recurring theme voiced by industry analysts for the past several years. Not too long ago, a report on the industry's tipping point suggested drugmakers would need to change their models and shift from their traditional emphasis on therapy to a service model. Now, a new report from Ernst & Young suggests that one way to make that switch from product-centric to customer-centric would be for Big Pharma to work with info-tech companies, retailers, telecoms, mobile phone companies and others not traditionally involved in health care.